Over-expression of BCL-XL or knock down of toxic BH3 domain proteins significantly reduced drug-induced tumor cell killing, however, expression of dominant negative caspase 9 was less protective than BCL-XL suggestive that both apoptotic and non-apoptotic cell killing was occurring. Here, BCL2L1 is linked to neoplasm.